ArticleRadiology case reports2026
Lymphoma of the cervix invading the uterine body with distant lymphadenopathy: MRI and FDG-PET/CT findings.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cervical lymphoma is a rare extranodal manifestation of non-Hodgkin lymphoma and may clinically and radiographically mimic primary cervical carcinoma. Involvement of the uterine body is even more uncommon and may further complicate diagnosis. We report the case of an 89-year-old woman who presented with heavy vaginal bleeding and was found to have diffuse large B-cell lymphoma (DLBCL) of the cervix with direct invasion into the uterine body and hypermetabolic pelvic, mediastinal, and supraclavicular lymphadenopathy. Multimodality imaging, including computed tomography (CT), magnetic resonance imaging (MRI), and fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT), demonstrated a markedly enlarged, hypermetabolic cervical mass with disruption of the normal three-zone cervical anatomy, preservation of the endocervical canal and smooth ectocervical contour, and marked restricted diffusion-features suggestive of cervical lymphoma rather than carcinoma. The patient was treated with palliative pelvic radiation for hemostasis followed by R-mini-CHOP chemotherapy (a dose-reduced regimen consisting of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) due to advanced age and frailty, resulting in a marked anatomic and metabolic response. This case highlights key MRI features that help differentiate cervical lymphoma from carcinoma and underscores the importance of tissue diagnosis to guide appropriate systemic therapy. Distinguishing cervical lymphoma from cervical carcinoma is clinically important, as treatment approaches differ substantially; cervical carcinoma is often managed surgically in early stages, whereas cervical lymphoma is treated primarily with systemic chemotherapy due to its inherently systemic nature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.